BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16710563)

  • 1. c-Ki-ras oncogene amplification and FGF2 signaling pathways in the mouse Y1 adrenocortical cell line.
    Forti FL; Costa ET; Rocha KM; Moraes MS; Armelin HA
    An Acad Bras Cienc; 2006 Jun; 78(2):231-9. PubMed ID: 16710563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin controls p27(Kip1) protein expression by PKC activation and irreversibly inhibits the proliferation of K-Ras-dependent mouse Y1 adrenocortical malignant cells.
    Forti FL; Armelin HA
    Biochim Biophys Acta; 2011 Aug; 1813(8):1438-45. PubMed ID: 21571010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTH promotion of p27(Kip1) induction in mouse Y1 adrenocortical tumor cells is dependent on both PKA activation and Akt/PKB inactivation.
    Forti FL; Schwindt TT; Moraes MS; Eichler CB; Armelin HA
    Biochemistry; 2002 Aug; 41(31):10133-40. PubMed ID: 12146978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell line.
    Costa ET; Forti FL; Rocha KM; Moraes MS; Armelin HA
    Endocr Res; 2004 Nov; 30(4):503-9. PubMed ID: 15666780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction in G0/G1-arrested mouse Y1 adrenocortical cells stimulated by ACTH and FGF2.
    Lepique AP; Forti FL; Moraes MS; Armelin HA
    Endocr Res; 2000 Nov; 26(4):825-32. PubMed ID: 11196459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstructing the molecular mechanisms of cell cycle control in a mouse adrenocortical cell line: roles of ACTH.
    Rocha KM; Forti FL; Lepique AP; Armelin HA
    Microsc Res Tech; 2003 Jun; 61(3):268-74. PubMed ID: 12768542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence.
    Costa ET; Forti FL; Matos TG; Dermargos A; Nakano F; Salotti J; Rocha KM; Asprino PF; Yoshihara CK; Koga MM; Armelin HA
    Cancer Res; 2008 Aug; 68(15):6215-23. PubMed ID: 18676845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF2 Antiproliferative Stimulation Induces Proteomic Dynamic Changes and High Expression of FOSB and JUNB in K-Ras-Driven Mouse Tumor Cells.
    Vitorino FNL; Montoni F; Moreno JN; de Souza BF; Lopes MC; Cordeiro B; Fonseca CS; Gilmore JM; Sardiu MI; Reis MS; Florens LA; Washburn MP; Armelin HA; da Cunha JPC
    Proteomics; 2018 Sep; 18(17):e1800203. PubMed ID: 30035358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ERK/MAP kinase in mitogenic interaction between ACTH and FGF2 in mouse Y1 adrenocortical tumor cells.
    Lotfi CF; Costa ET; Schwindt TT; Armelin HA
    Endocr Res; 2000 Nov; 26(4):873-7. PubMed ID: 11196465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine vasopressin inhibition of cyclin D1 gene expression blocks the cell cycle and cell proliferation in the mouse Y1 adrenocortical tumor cell line.
    Schwindt TT; Forti FL; Juliano MA; Juliano L; Armelin HA
    Biochemistry; 2003 Feb; 42(7):2116-21. PubMed ID: 12590600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.
    Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ
    Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth control in mouse Y-1 adrenocortical tumor cells: role of c-Ki-ras amplification and effects of ACTH.
    Kimura E; Armelin HA
    Arch Biol Med Exp; 1988 Dec; 21(3-4):435-41. PubMed ID: 2855698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of proto-oncogene c-Ki-ras amplification and overexpression in the malignancy of Y-1 adrenocortical tumor cells.
    Kimura E; Armelin HA
    Braz J Med Biol Res; 1988; 21(2):189-201. PubMed ID: 3060206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTH inhibits A Ras-dependent anti-apoptotic and mitogenic pathway in mouse Y1 adrenocortical cells.
    Forti FL; Armelin HA
    Endocr Res; 2000 Nov; 26(4):911-4. PubMed ID: 11196470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
    Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
    PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between the growth regulatory pathways in primary rat adrenal cells and mouse tumor cell line.
    Mattos GE; Lotfi CF
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):31-42. PubMed ID: 16289304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.
    Schwab M; Alitalo K; Varmus HE; Bishop JM; George D
    Nature; 1983 Jun 9-15; 303(5917):497-501. PubMed ID: 6304530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
    Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS
    Carcinogenesis; 2005 Dec; 26(12):2196-206. PubMed ID: 16051643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.